BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease

Abstract excerpt

The aim of the present study was to determine if patients with both pulmonary arterial hypertension (PAH), due to pulmonary vascular obstructive disease, and congenital heart defects (CHD), have mutations in the gene encoding bone morphogenetic protein receptor (BMPR)-2. The BMPR2 gene was screened in two cohorts: 40 adults and 66 children with PAH/CHD. CHDs were patent ductus arteriosus, atrial and ventricular...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cardiovascular Issues in Pregnancy
• Share to Congenital Heart Disease Studies
• Share to Pulmonary Hypertension Research and Treatments